CorMedixvsThermo Fisher Scientific

CRMD and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$691.33

Value $257B

-1.27%
TMO's page

CorMedix (CRMD) has a market value of $381M and Thermo Fisher Scientific (TMO) $257B. Over the last year, with dividends, CRMD moved -57.1% and TMO +19.9%. The P/E is 6.0 for CRMD and 36.3 for TMO. Dividend yield: CRMD none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    CRMD$381M

    TMO$257B

    TMO is 674 times CRMD

  • Revenue, 12 months

    CRMD$412M

    TMO$47.4B

    TMO is 115 times CRMD

  • Net income, 12 months

    CRMD$64M

    TMO$7.1B

    TMO is 111 times CRMD

  • Operating margin

    CRMD38.6%

    TMO17.9%

    20.7 points apart

  • ROIC

    CRMD27.3%

    TMO8.2%

    19.1 points apart

  • P/E

    CRMD6.0

    TMO36.3

    TMO is 6.1 times CRMD

  • Dividend yield

    CRMD0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    CRMD-7.3%

    TMO+10.9%

    18.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

CRMD-7.3%

TMO+10.9%

10020030020222023202420252026
Returns by period
PeriodCRMDWith dividendsTMOWith dividends
1 year since November 14, 2025-57.1%Price -57.1%+19.9%Price +19.5%
3 years since November 16, 2023+26.8%+8.2% a yearPrice +26.8%+47.7%+13.9% a yearPrice +46.3%
5 years since November 15, 2021-7.3%-1.5% a yearPrice -7.3%+10.9%+2.1% a yearPrice +9.3%
10 years since November 16, 2016-43.6%-5.6% a yearPrice -43.6%+375.7%+16.9% a yearPrice +362.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

CRMDCorMedixTMOThermo Fisher Scientific

Valuation

CRMDTMO
Valuation
Price$4.82$691.33
Market value$381M$257B
Enterprise value (EV)$26M$292B
P/E6.036.3
P/E, 5-year median–32.7
P/B0.84.7
EV/EBIT0.234.5
Free cash flow yield80.8%3.0%

Results and growth

CRMDTMO
Results and growth
Revenue, 12 months$412M$47.4B
Net income, 12 months$64M$7.1B
Free cash flow, 12 months$308M$7.6B
Earnings per share, 12 months$0.81$18.96
Revenue growth, year on year617.0%3.9%
Revenue growth a year, past+319.8%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

CRMDTMO
Margins and returns on capital
Gross margin77.5%–
Operating margin38.6%17.9%
Net margin15.5%14.9%
ROIC27.3%8.2%
ROE14.9%13.4%

Balance sheet

CRMDTMO
Balance sheet
Cash$355M$6.1B
Total debt$144.6K$41.4B
Net debt / EBITDA-2.23.7
Interest cover57.2×5.5×

Dividends and buybacks

CRMDTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: CRMD or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, CorMedix or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($257B) is about 674.0 times CorMedix ($381M), at today's prices.

How did CRMD and TMO stock do over the last 10 years?

Since November 16, 2016, CRMD's price moved -43.6% and TMO's +362.5%. With dividends: CRMD -43.6% (-5.6% a year), TMO +375.7% (+16.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, CRMD or TMO?

The dividend yield at today's price is none for CorMedix and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

What is the P/E of CRMD and TMO?

At today's price, the P/E is 6.0 for CRMD and 36.3 for TMO. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, CorMedix or Thermo Fisher Scientific?

Over the last twelve months, the net margin was 15.5% for CorMedix and 14.9% for Thermo Fisher Scientific, and the operating margin 38.6% and 17.9%. Revenue was $412M and $47.4B.

Which is the better investment, CorMedix or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.